NADPH-oxidase but not inducible nitric oxide synthase contributes to resistance in a murine Staphylococcus aureus Newman pneumonia model

Microbes and Infection

Volumn 13, Issue 11, 2011, Pages 914-922

  Köhler, Jens ^a   Breitbach, Katrin ^a   Renner, Cäcilia ^a   Heitsch, Anne Katrin ^a   Bast, Antje ^a   van Rooijen, Nico ^b   Vogelgesang, Silke ^a   Steinmetz, Ivo ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Macrophage; NADPH oxidase; Neutrophil; Nitric oxide; Staphylococcus aureus

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; INFECTION SENSITIVITY; INNATE IMMUNITY; LEUKOPENIA; LUNG ALVEOLUS MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; STAPHYLOCOCCAL PNEUMONIA;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE II; PNEUMONIA, STAPHYLOCOCCAL; RODENT DISEASES; STAPHYLOCOCCUS AUREUS;

MURINAE; MUS; STAPHYLOCOCCUS AUREUS;

EID: 80052361126     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.05.004     Document Type: Article

References (44)

1. Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339:520-532.
2. Kollef M.H., Shorr A., Tabak Y.P., Gupta V., Liu L.Z., Johannes R.S. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005, 128:3854-3862.
3. Kollef M.H., Morrow L.E., Niederman M.S., Leeper K.V., Anzueto A., Benz-Scott L., Rodino F.J. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006, 129:1210-1218.
4. Howden B.P., Johnson P.D., Charles P.G., Grayson M.L. Failure of vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections. Clin. Infect. Dis. 2004, 39:1544-1545. 1544 author reply.
5. Howe R.A., Monk A., Wootton M., Walsh T.R., Enright M.C. Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg. Infect. Dis. 2004, 10:855-857.
6. Bubeck Wardenburg J., Patel R.J., Schneewind O. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun. 2007, 75:1040-1044.
7. Mason W.J., Skaar E.P. Assessing the contribution of heme-iron acquisition to Staphylococcus aureus pneumonia using computed tomography. PLoS One 2009, 4. e6668.
8. Sawai T., Tomono K., Yanagihara K., Yamamoto Y., Kaku M., Hirakata Y., Koga H., Tashiro T., Kohno S. Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect. Immun. 1997, 65:466-471.
9. Villaruz A.E., Bubeck Wardenburg J., Khan B.A., Whitney A.R., Sturdevant D.E., Gardner D.J., DeLeo F.R., Otto M. A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation,. J. Infect. Dis. 2009, 200:724-734.
10. Torres V.J., Attia A.S., Mason W.J., Hood M.I., Corbin B.D., Beasley F.C., Anderson K.L., Stauff D.L., McDonald W.H., Zimmerman L.J., Friedman D.B., Heinrichs D.E., Dunman P.M., Skaar E.P. Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia. Infect. Immun. 2010, 78:1618-1628.
11. Kapetanovic R., Jouvion G., Fitting C., Parlato M., Blanchet C., Huerre M., Cavaillon J.M., Adib-Conquy M. Contribution of NOD2 to lung inflammation during Staphylococcus aureus-induced pneumonia. Microbes Infect. 2010, 12:759-767.
12. Banerjee A., Stevenaert F., Pande K., Haghjoo E., Antonenko S., Gorman D.M., Sathe M., McClanahan T.K., Pierce R., Turner S.P., Bigler M.E., Phillips J.H., Heyworth P.G. Modulation of paired immunoglobulin-like type 2 receptor signaling alters the host response to Staphylococcus aureus-induced pneumonia. Infect. Immun. 2010, 78:1353-1363.
13. Small C.L., McCormick S., Gill N., Kugathasan K., Santosuosso M., Donaldson N., Heinrichs D.E., Ashkar A., Xing Z. NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung. J. Immunol. 2008, 180:5558-5568.
14. von Kockritz-Blickwede M., Rohde M., Oehmcke S., Miller L.S., Cheung A.L., Herwald H., Foster S., Medina E. Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. Am. J. Pathol. 2008, 173:1657-1668.
15. Robertson C.M., Perrone E.E., McConnell K.W., Dunne W.M., Boody B., Brahmbhatt T., Diacovo M.J., Van Rooijen N., Hogue L.A., Cannon C.L., Buchman T.G., Hotchkiss R.S., Coopersmith C.M. Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance. J. Surg. Res. 2008, 150:278-285.
16. Kielian T., Barry B., Hickey W.F. CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J. Immunol. 2001, 166:4634-4643.
17. Ellson C.D., Davidson K., Ferguson G.J., O'Connor R., Stephens L.R., Hawkins P.T. Neutrophils from p40phox-/- mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing. J. Exp. Med. 2006, 203:1927-1937.
18. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
19. Cunha F.Q., Moss D.W., Leal L.M., Moncada S., Liew F.Y. Induction of macrophage parasiticidal activity by Staphylococcus aureus and exotoxins through the nitric oxide synthesis pathway. Immunology 1993, 78:563-567.
20. De Kimpe S.J., Kengatharan M., Thiemermann C., Vane J.R. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. U S A 1995, 92:10359-10363.
21. Kuo C.T., Chiang L.L., Lee C.N., Yu M.C., Bai K.J., Lee H.M., Lee W.S., Sheu J.R., Lin C.H. Induction of nitric oxide synthase in RAW 264.7 macrophages by lipoteichoic acid from Staphylococcus aureus: involvement of protein kinase C- and nuclear factor-kB-dependent mechanisms. J. Biomed. Sci. 2003, 10:136-145.
22. Richardson A.R., Libby S.J., Fang F.C. A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity,. Science 2008, 319:1672-1676.
23. Messina C.G., Reeves E.P., Roes J., Segal A.W. Catalase negative Staphylococcus aureus retain virulence in mouse model of chronic granulomatous disease. FEBS Lett. 2002, 518:107-110.
24. Van Rooijen N., Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 1994, 174:83-93.
25. Mircescu M.M., Lipuma L., van Rooijen N., Pamer E.G., Hohl T.M. Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J. Infect. Dis. 2009, 200:647-656.
26. El Bakkouri K., Descamps F., De Filette M., Smet A., Festjens E., Birkett A., Van Rooijen N., Verbeek S., Fiers W., Saelens X. Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection. J. Immunol. 2011, 186:1022-1031.
27. Rivera R., Hutchens M., Luker K.E., Sonstein J., Curtis J.L., Luker G.D. Murine alveolar macrophages limit replication of vaccinia virus. Virology 2007, 363:48-58.
28. Thepen T., Van Rooijen N., Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J. Exp. Med. 1989, 170:499-509.
29. Easton A., Haque A., Chu K., Lukaszewski R., Bancroft G.J. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J. Infect. Dis. 2007, 195:99-107.
30. Stirling D.P., Liu S., Kubes P., Yong V.W. Depletion of Ly6G/Gr-1 leukocytes after spinal cord injury in mice alters wound healing and worsens neurological outcome. J. Neurosci. 2009, 29:753-764.
31. Eske K., Breitbach K., Kohler J., Wongprompitak P., Steinmetz I. Generation of murine bone marrow derived macrophages in a standardised serum-free cell culture system. J. Immunol. Methods 2009, 342:13-19.
32. Hume E.B., Cole N., Khan S., Garthwaite L.L., Aliwarga Y., Schubert T.L., Willcox M.D. A Staphylococcus aureus mouse keratitis topical infection model: cytokine balance in different strains of mice. Immunol. Cell Biol. 2005, 83:294-300.
33. Leemans J.C., Juffermans N.P., Florquin S., van Rooijen N., Vervoordeldonk M.J., Verbon A., van Deventer S.J., van der Poll T. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J. Immunol. 2001, 166:4604-4611.
34. McInnes I.B., Leung B., Wei X.Q., Gemmell C.C., Liew F.Y. Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase. J. Immunol. 1998, 160:308-315.
35. Miller L.S., Pietras E.M., Uricchio L.H., Hirano K., Rao S., Lin H., O'Connell R.M., Iwakura Y., Cheung A.L., Cheng G., Modlin R.L. Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo. J. Immunol. 2007, 179:6933-6942.
36. Verdrengh M., Tarkowski A. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect. Immun. 1997, 65:2517-2521.
37. Gresham H.D., Lowrance J.H., Caver T.E., Wilson B.S., Cheung A.L., Lindberg F.P. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J. Immunol. 2000, 164:3713-3722.
38. Molne L., Verdrengh M., Tarkowski A. Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect. Immun. 2000, 68:6162-6167.
39. Itoh N., Shibayama H., Kanekiyo M., Namphung D., Nakanishi T., Matsuyama A., Odani T., Tanaka K. Reduced bactericidal activity and nitric oxide production in metallothionein-deficient macrophages in response to lipopolysaccharide stimulation. Toxicology 2005, 216:188-196.
40. Takeuchi O., Hoshino K., Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 2000, 165:5392-5396.
41. Sakiniene E., Bremell T., Tarkowski A. Inhibition of nitric oxide synthase (NOS) aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin. Exp. Immunol. 1997, 110:370-377.
42. Sasaki S., Miura T., Nishikawa S., Yamada K., Hirasue M., Nakane A. Protective role of nitric oxide in Staphylococcus aureus infection in mice. Infect. Immun. 1998, 66:1017-1022.
43. Huang J., DeGraves F.J., Lenz S.D., Gao D., Feng P., Li D., Schlapp T., Kaltenboeck B. The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease. Proc. Natl. Acad. Sci. U S A 2002, 99:3914-3919.
44. Schluter D., Deckert-Schluter M., Lorenz E., Meyer T., Rollinghoff M., Bogdan C. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice. J. Immunol. 1999, 162:3512-3518.